+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Medical Foods Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2026
  • Region: Europe
  • Grand View Research
  • ID: 6024641
The Europe medical foods market size was valued at USD 6.3 billion in 2025 and is projected to grow from USD 6.5 billion in 2026 to USD 7.9 billion by 2033, growing at a CAGR of 2.8% from 2026 to 2033. The growth is attributed to Europe’s large and aging population, which is increasingly susceptible to chronic and age-related conditions, including cardiovascular and respiratory diseases, thereby driving demand for specialized nutritional solutions and medical foods to support disease management and improve overall health outcomes.

Europe Medical Foods Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Europe medical foods market report based on route of administration, product, application, modules, sales channel, and region.

Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)

  • Oral
  • Enteral

Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Pills
  • Powder
  • Liquid
  • Others (semisolid, semiliquid)

Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy Induced Diarrhoea
  • Pathogen Related Infections
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer's Disease
  • Nutritional Deficiency
  • Orphan Diseases
  • Tyrosinemia
  • Eosinophilic Esophagitis
  • Food Protein Module-induced enterocolitis syndrome (FPIES)
  • Phenylketonuria (PKU)
  • Maple syrup urine disease (MSUD)
  • Homocystinuria
  • Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)
  • Wound Healing
  • Chronic Diarrhea
  • Constipation Relief
  • Protein Booster
  • Dysphagia
  • Pain Management
  • Parkinson's Disease
  • Epilepsy
  • Other Cancer related treatments
  • Severe Protein Allergy
  • Cancer
  • Cachexia
  • Other (debilitating conditions, COPD, etc.)

Modules Outlook (Revenue, USD Billion, 2021 - 2033)

  • Amino Acid Module
  • Protein Module
  • Vitamin & Mineral Modules
  • Fatty Acid based Modules
  • Carbohydrate Modules
  • Fiber Modules
  • Ketogenic Modules
  • Peptide based Modules
  • Hypoallergic Modules
  • Others (Electrolyte Module, etc.)

Sales Channel Outlook (Revenue, USD Billion, 2021 - 2033)

  • DTC Sales Channel
  • Online Sales
  • Retail Sales
  • Institutional Sales
  • Hospitals
  • Others (Long-term Care Facilities, etc.)

Country Outlook (Revenue, USD Billion, 2021 - 2033)

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Denmark
  • Sweden
  • Norway
  • Poland
  • Netherlands
  • Portugal
  • Slovakia
  • Finland
  • Czech Republic
  • Hungary
  • Belgium

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Route of Administration
1.1.2. Product
1.1.3. Application
1.1.4. Modules
1.1.5. Sales Channel
1.1.6. Country scope
1.2. Estimates and forecast timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database.
1.4.2. The internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Route of administration outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. Modules outlook
2.2.5. Sales channel outlook
2.2.6. Country outlook
2.3. Competitive Insights
Chapter 3. Europe Medical Foods Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of chronic diseases
3.2.1.2. Increasing Geriatric Population and Chronic Disease Burden
3.2.1.3. Rising Nutritional Deficiencies and Malnutrition
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Specialized Medical Foods
3.2.2.2. Reimbursement and Insurance Limitations
3.3. Regulatory Framework
3.4. Pricing Analysis (Oral & Enteral)
3.4.1. Standardized pricing by form of product, country (2025)
3.4.1.1. UK
3.4.1.2. Germany
3.4.1.3. Spain
3.4.1.4. France
3.4.1.5. Italy
3.4.1.6. Denmark
3.4.1.7. Sweden
3.4.1.8. Norway
3.4.1.9. Poland
3.4.1.10. Netherlands
3.4.1.11. Portugal
3.4.1.12. Slovakia
3.4.1.13. Finland
3.4.1.14. Czech Republic
3.4.1.15. Hungary
3.4.1.16. Belgium
3.5. Industry Analysis
3.5.1. User Perspective Analysis
3.5.2. Key End Users
3.6. Technology Outlook
3.6.1. Technology Timeline
3.7. Europe Medical Foods Market Analysis Tools
3.7.1. Industry Analysis - Porter’s Five Forces
3.7.1.1. Supplier power
3.7.1.2. Buyer power
3.7.1.3. Substitution threat
3.7.1.4. Threat of new entrant
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political landscape
3.7.2.2. Economic landscape
3.7.2.3. Social landscape
3.7.2.4. Technological landscape
3.7.2.5. Environmental landscape
3.7.2.6. Legal landscape
Chapter 4. Europe Medical Foods Market: Route of Administration Estimates & Trend Analysis
4.1. Route of Administration Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Europe Medical Foods Market by Route of Administration Outlook
4.4. Oral
4.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
4.5. Enteral
4.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
Chapter 5. Europe Medical Foods Market: Product Estimates & Trend Analysis
5.1. Product Market Share, 2025 & 2033
5.2. Segment Dashboard
5.3. Europe Medical Foods Market by Product Outlook
5.4. Pills
5.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
5.5. Powder
5.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
5.6. Liquid
5.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
5.7. Others (semisolid, semiliquid)
5.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
Chapter 6. Europe Medical Foods Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2025 & 2033
6.2. Segment Dashboard
6.3. Europe Medical Foods Market by Application Outlook
6.4. Chronic Kidney Disease
6.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.5. Minimal Hepatic Encephalopathy
6.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.6. Chemotherapy Induced Diarrhea
6.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.7. Pathogen Related Infections
6.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.8. Diabetic Neuropathy
6.8.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.9. ADHD
6.9.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.10. Depression
6.10.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.11. Alzheimer's Disease
6.11.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.12. Nutritional Deficiency
6.12.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13. Orphan Diseases
6.13.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.2. Tyrosinemia
6.13.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.3. Eosinophilic Esophagitis
6.13.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.4. Food Protein Module-induced enterocolitis syndrome (FPIES)
6.13.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.5. Phenylketonuria (PKU)
6.13.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.6. Maple syrup urine disease (MSUD)
6.13.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.7. Homocystinuria
6.13.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.13.8. Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)
6.13.8.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.14. Wound Healing
6.14.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.15. Chronic Diarrhea
6.15.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.16. Constipation Relief
6.16.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.17. Protein Booster
6.17.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.18. Dysphagia
6.18.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.19. Pain Management
6.19.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.20. Parkinson's Disease
6.20.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.21. Epilepsy
6.21.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.22. Other Cancer related treatments
6.22.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.23. Severe Protein Allergy
6.23.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.24. Cancer
6.24.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.25. Cachexia
6.25.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
6.26. Other (debilitating conditions, COPD, etc.)
6.26.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
Chapter 7. Europe Medical Foods Market: Modules Estimates & Trend Analysis
7.1. Modules Market Share, 2025 & 2033
7.2. Segment Dashboard
7.3. Europe Medical Foods Market by Modules Outlook
7.4. Amino Acid Module
7.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.5. Protein Module
7.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.6. Vitamin & Mineral Modules
7.6.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.7. Fatty Acid based Modules
7.7.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.8. Carbohydrate Modules
7.8.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.9. Fiber Modules
7.9.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.10. Ketogenic Modules
7.10.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.11. Peptide based Modules
7.11.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.12. Hypoallergic Modules
7.12.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
7.13. Others (Electrolyte Module, etc.)
7.13.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
Chapter 8. Europe Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1. Sales Channel Market Share, 2025 & 2033
8.2. Segment Dashboard
8.3. Europe Medical Foods Market by Sales Channel Outlook
8.4. DTC Sales Channel
8.4.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
8.4.2. Online Sales
8.4.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
8.4.3. Retail Sales
8.4.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
8.5. Institutional Sales
8.5.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
8.5.2. Hospitals
8.5.2.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
8.5.3. Others (Long-term Care Facilities, etc.)
8.5.3.1. Market estimates and forecast, 2021 - 2033 (USD Billion)
Chapter 9. Europe Medical Foods Market: Country Estimates & Trend Analysis, Route of Administration, Product, Application, Modules, Sales Channel
9.1. Country Market Share Analysis, 2025 & 2033
9.2. Country Market Dashboard
9.3. Country Market Snapshot
9.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.3. Spain
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.4. France
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Competitive scenario
9.4.4.4. France market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.5. Italy
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework
9.4.5.3. Competitive scenario
9.4.5.4. Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework
9.4.6.3. Competitive scenario
9.4.6.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework
9.4.8.3. Competitive scenario
9.4.8.4. Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.9. Poland
9.4.9.1. Key country dynamics
9.4.9.2. Regulatory framework
9.4.9.3. Competitive scenario
9.4.9.4. Poland market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.10. Netherlands
9.4.10.1. Key country dynamics
9.4.10.2. Regulatory framework
9.4.10.3. Competitive scenario
9.4.10.4. Netherlands market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.11. Portugal
9.4.11.1. Key country dynamics
9.4.11.2. Regulatory framework
9.4.11.3. Competitive scenario
9.4.11.4. Portugal market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.12. Slovakia
9.4.12.1. Key country dynamics
9.4.12.2. Regulatory framework
9.4.12.3. Competitive scenario
9.4.12.4. Slovakia market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.13. Finland
9.4.13.1. Key country dynamics
9.4.13.2. Regulatory framework
9.4.13.3. Competitive scenario
9.4.13.4. Finland market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.14. Czech Republic
9.4.14.1. Key country dynamics
9.4.14.2. Regulatory framework
9.4.14.3. Competitive scenario
9.4.14.4. Czech Republic market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.15. Hungary
9.4.15.1. Key country dynamics
9.4.15.2. Regulatory framework
9.4.15.3. Competitive scenario
9.4.15.4. Hungary market estimates and forecasts, 2021 - 2033 (USD Billion)
9.4.16. Belgium
9.4.16.1. Key country dynamics
9.4.16.2. Regulatory framework
9.4.16.3. Competitive scenario
9.4.16.4. Belgium market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Company Market Position Analysis, 2025
10.3. Company Market Share Analysis, 2025
10.3.1. Company Market Share Analysis for Oral Medical Foods, 2025
10.3.2. Company Market Share Analysis for Enteral Medical Foods, 2025
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Danone (Nutricia)
10.5.1.1. Company overview
10.5.1.2. Financial performance
10.5.1.3. Product benchmarking
10.5.1.4. Strategic initiatives
10.5.2. Nestlé Health Science
10.5.2.1. Company overview
10.5.2.2. Financial performance
10.5.2.3. Product benchmarking
10.5.2.4. Strategic initiatives
10.5.3. Abbott
10.5.3.1. Company overview
10.5.3.2. Financial performance
10.5.3.3. Product benchmarking
10.5.3.4. Strategic initiatives
10.5.4. Targeted Medical Pharma, Inc. (Physician Therapeutics, LLC, is a division of the company)
10.5.4.1. Company overview
10.5.4.2. Financial performance
10.5.4.3. Product benchmarking
10.5.4.4. Strategic initiatives
10.5.5. Primus Pharmaceuticals, Inc.
10.5.5.1. Company overview
10.5.5.2. Financial performance
10.5.5.3. Product benchmarking
10.5.5.4. Strategic initiatives
10.5.6. Fresenius Kabi AG
10.5.6.1. Company overview
10.5.6.2. Financial performance
10.5.6.3. Product benchmarking
10.5.6.4. Strategic initiatives
10.5.7. Mead Johnson & Company, LLC
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.6. List of other market players
List of Tables
Table 1 List of abbreviations
Table 2 List of Secondary Sources
Table 3 Europe medical foods market, region, 2021 - 2033 (USD Billion)
Table 4 Europe medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 5 Europe medical foods market, product, 2021 - 2033 (USD Billion)
Table 6 Europe medical foods market, application, 2021 - 2033 (USD Billion)
Table 7 Europe medical foods market, modules, 2021 - 2033 (USD Billion)
Table 8 Europe medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 9 Germany medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 10 Germany medical foods market, product, 2021 - 2033 (USD Billion)
Table 11 Germany medical foods market, application, 2021 - 2033 (USD Billion)
Table 12 Germany medical foods market, modules, 2021 - 2033 (USD Billion)
Table 13 Germany medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 14 UK medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 15 UK medical foods market, product, 2021 - 2033 (USD Billion)
Table 16 UK medical foods market, application, 2021 - 2033 (USD Billion)
Table 17 UK medical foods market, modules, 2021 - 2033 (USD Billion)
Table 18 UK medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 19 France medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 20 France medical foods market, product, 2021 - 2033 (USD Billion)
Table 21 France medical foods market, application, 2021 - 2033 (USD Billion)
Table 22 France medical foods market, modules, 2021 - 2033 (USD Billion)
Table 23 France medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 24 Italy medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 25 Italy medical foods market, product, 2021 - 2033 (USD Billion)
Table 26 Italy medical foods market, application, 2021 - 2033 (USD Billion)
Table 27 Italy medical foods market, modules, 2021 - 2033 (USD Billion)
Table 28 Italy medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 29 Spain medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 30 Spain medical foods market, product, 2021 - 2033 (USD Billion)
Table 31 Spain medical foods market, application, 2021 - 2033 (USD Billion)
Table 32 Spain medical foods market, modules, 2021 - 2033 (USD Billion)
Table 33 Spain medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 34 Denmark medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 35 Denmark medical foods market, product, 2021 - 2033 (USD Billion)
Table 36 Denmark medical foods market, application, 2021 - 2033 (USD Billion)
Table 37 Denmark medical foods market, modules, 2021 - 2033 (USD Billion)
Table 38 Denmark medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 39 Sweden medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 40 Sweden medical foods market, product, 2021 - 2033 (USD Billion)
Table 41 Sweden medical foods market, application, 2021 - 2033 (USD Billion)
Table 42 Sweden medical foods market, modules, 2021 - 2033 (USD Billion)
Table 43 Sweden medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 44 Norway medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 45 Norway medical foods market, product, 2021 - 2033 (USD Billion)
Table 46 Norway medical foods market, application, 2021 - 2033 (USD Billion)
Table 47 Norway medical foods market, modules, 2021 - 2033 (USD Billion)
Table 48 Norway medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 49 Poland medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 50 Poland medical foods market, product, 2021 - 2033 (USD Billion)
Table 51 Poland medical foods market, application, 2021 - 2033 (USD Billion)
Table 52 Poland medical foods market, modules, 2021 - 2033 (USD Billion)
Table 53 Poland medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 54 Netherlands medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 55 Netherlands medical foods market, product, 2021 - 2033 (USD Billion)
Table 56 Netherlands medical foods market, application, 2021 - 2033 (USD Billion)
Table 57 Netherlands medical foods market, modules, 2021 - 2033 (USD Billion)
Table 58 Netherlands medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 59 Portugal medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 60 Portugal medical foods market, product, 2021 - 2033 (USD Billion)
Table 61 Portugal medical foods market, application, 2021 - 2033 (USD Billion)
Table 62 Portugal medical foods market, modules, 2021 - 2033 (USD Billion)
Table 63 Portugal medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 64 Slovakia medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 65 Slovakia medical foods market, product, 2021 - 2033 (USD Billion)
Table 66 Slovakia medical foods market, application, 2021 - 2033 (USD Billion)
Table 67 Slovakia medical foods market, modules, 2021 - 2033 (USD Billion)
Table 68 Slovakia medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 69 Finland medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 70 Finland medical foods market, product, 2021 - 2033 (USD Billion)
Table 71 Finland medical foods market, application, 2021 - 2033 (USD Billion)
Table 72 Finland medical foods market, modules, 2021 - 2033 (USD Billion)
Table 73 Finland medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 74 Czech Republic medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 75 Czech Republic medical foods market, product, 2021 - 2033 (USD Billion)
Table 76 Czech Republic medical foods market, application, 2021 - 2033 (USD Billion)
Table 77 Czech Republic medical foods market, modules, 2021 - 2033 (USD Billion)
Table 78 Czech Republic medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 79 Hungary medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 80 Hungary medical foods market, product, 2021 - 2033 (USD Billion)
Table 81 Hungary medical foods market, application, 2021 - 2033 (USD Billion)
Table 82 Hungary medical foods market, modules, 2021 - 2033 (USD Billion)
Table 83 Hungary medical foods market, sales channel, 2021 - 2033 (USD Billion)
Table 84 Belgium medical foods market, route of administration, 2021 - 2033 (USD Billion)
Table 85 Belgium medical foods market, product, 2021 - 2033 (USD Billion)
Table 86 Belgium medical foods market, application, 2021 - 2033 (USD Billion)
Table 87 Belgium medical foods market, modules, 2021 - 2033 (USD Billion)
Table 88 Belgium medical foods market, sales channel, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Europe medical foods market: market outlook
Figure 9 Parent market outlook
Figure 10 Related/ancillary market outlook
Figure 11 Penetration and growth prospect mapping
Figure 12 Industry value chain analysis
Figure 13 Europe medical foods market driver impact
Figure 14 Europe medical foods market restraint impact
Figure 15 Europe medical foods market strategic initiatives analysis
Figure 16 Europe medical foods market: Route of administration movement analysis
Figure 17 Europe medical foods market: Route of administration outlook and key takeaways
Figure 18 Oral market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 19 Enteral market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 20 Europe medical foods market: Product movement analysis
Figure 21 Europe medical foods market: Product outlook and key takeaways
Figure 22 Pills market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 23 Powder market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 24 Liquid market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 25 Others (semisolid, semiliquid) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 26 Europe medical foods market: Application model analysis
Figure 27 Europe medical foods market: Application model outlook and key takeaways
Figure 28 Chronic kidney disease market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 29 Minimal hepatic encephalopathy market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 30 Chemotherapy induced diarrhea market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 31 Pathogen related infections market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 32 Diabetic neuropathy market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 33 ADHD market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 34 Depression market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 35 Alzheimer's disease market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 36 Nutritional deficiency market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 37 Orphan diseases market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 38 Tyrosinemia market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 39 Eosinophilic Esophagitis market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 40 Food Protein Module-induced enterocolitis syndrome (FPIES) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 41 Phenylketonuria (PKU) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 42 Maple syrup urine disease (MSUD) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 43 Homocystinuria market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 44 Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 45 Wound healing market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 46 Chronic diarrhea market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 47 Constipation relief market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 48 Protein booster market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 49 Dysphagia market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 50 Pain management market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 51 Parkinson's disease market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 52 Epilepsy market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 53 Other cancer related treatments market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 54 Severe protein allergy market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 55 Cancer market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 56 Chacexia market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 57 Other (debilitating conditions, COPD, etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 58 Europe medical foods market: Modules model analysis
Figure 59 Europe medical foods market: Modules model outlook and key takeaways
Figure 60 Amino acid module market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 61 Protein module market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 62 Vitamin & mineral modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 63 Fatty acid based modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 64 Carbohydrate modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 65 Fiber modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 66 Ketogenic modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 67 Peptide based modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 68 Hypoallergic modules market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 69 Others (electrolyte module, etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 70 Europe medical foods market: Sales channel model analysis
Figure 71 Europe medical foods market: Sales channel model outlook and key takeaways
Figure 72 DTC sales channel market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 73 Online sales market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 74 Retail sales market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 75 Institutional sales market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 76 Hospitals market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 77 Others (long-term care facilities, etc.) market estimates and forecast, 2021 - 2033 (USD Billion)
Figure 78 Europe medical foods market: Country movement analysis
Figure 79 Europe medical foods market: Country outlook and key takeaways
Figure 80 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 81 UK
Figure 82 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 83 Germany
Figure 84 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 85 France
Figure 86 France market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 87 Italy
Figure 88 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 89 Spain
Figure 90 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 91 Denmark
Figure 92 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 93 Sweden
Figure 94 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 95 Norway
Figure 96 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 97 Poland
Figure 98 Poland market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 99 Netherlands
Figure 100 Netherlands market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 101 Portugal
Figure 102 Portugal market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 103 Slovakia
Figure 104 Slovakia market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 105 Finland
Figure 106 Finland market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 107 Czech Republic
Figure 108 Czech Republic market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 109 Hungary
Figure 110 Hungary market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 111 Belgium
Figure 112 Belgium market estimates and forecasts, 2021 - 2033 (USD Billion)

Companies Mentioned

  • Danone
  • Nestlé
  • Abbott
  • Targeted Medical Pharma, Inc. (Physician Therapeutics, LLC, is a division of the company)
  • Primus Pharmaceuticals, Inc.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC